16 March 2021 · Medicines with RMM may not be suitable for inclusion within Patient Group Directions (PGDs). If used, the RMM must be stated within the PGD.
15 December 2022 · Practical guidance to ensure opportunities to learn from local intelligence, including patient harm are translated into shared local and national learning
27 September 2023 · Discussion of key current medication safety challenges within healthcare with a focus on medication inequalities; inspiring partnership across the system.
28 February 2024 · Discussion of key current medication safety challenges within healthcare with a focus on the safe use of valproate; inspiring partnership across the system
29 April 2024 · Exploring the risks for patients on complex or specialist medicines moving across care boundaries with a focus on strategies to reduce harms
20 December 2021 · Differing models exist for the supply and administration of COVID-19 treatments. We guide through the risks and mitigations associated with each.
9 July 2021 · Serious side effects can be caused if betamethasone soluble tablets used as mouthwash are swallowed. Providing clear patient directions can help prevent harm.
9 March 2023 · Careful use of effervescent or soluble tablets to deliver part tablet doses for children and neonates can minimise risks of toxicity or suboptimal therapy.